TELO
NASDAQ · Pharmaceuticals
Telomir Pharmaceuticals Inc
$0.78
-0.09 (-10.85%)
Open$0.83
Previous Close$0.88
Day High$0.87
Day Low$0.78
52W High$1.58
52W Low$0.78
Volume—
Avg Volume92.6K
Market Cap57.47M
P/E Ratio—
EPS$-0.15
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 9.55M | 10.11M | 8.56M |
| Net Income | 1.76M | 2.03M | 1.53M |
| Profit Margin | 18.4% | 20.1% | 17.9% |
| EBITDA | 2.43M | 2.63M | 2.21M |
| Free Cash Flow | 1.02M | 1.59M | 1.30M |
| Rev Growth | -2.0% | +7.8% | +19.7% |
| Debt/Equity | 0.60 | 0.70 | 0.67 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |